ArticleCureus2025
Virtual Reality Headset as a Cause of Allergic Contact Dermatitis in a Child.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Allergic contact dermatitis (ACD) from gaming accessories is rarely reported. With the increasing popularity of virtual reality (VR) headsets, more cases may emerge. We report the case of a 13-year-old boy with atopic eczema who developed a recurrent periorbital rash at sites contacting an Oculus Quest 2 headset (Meta Platforms, Menlo Park, CA, USA). He was otherwise healthy, on no medications, and had a family history of asthma. Patch testing included the British standard, medicament, facial, and photosensitivity series, with the headset foam added on day two. Positive reactions were observed to methylisothiazolinone, methylchloroisothiazolinone/methylisothiazolinone (MCI/MI), 2-bromo-2-nitropropane-1,3-diol, methyldibromoglutaronitrile, benzisothiazolinone, propolis, Carba Mix, and the headset foam. Symptoms resolved fully following replacement of the foam interface with a silicone cover. This case expands the spectrum of wearable-device-related allergic contact dermatitis and underscores the importance of including device materials in patch-test panels. It also highlights the need to consider wearable electronics as emerging sources of paediatric ACD.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.